Key facts
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G/A for EyePoint, Inc. Common Stock, $0.001 par value per share (EYPT).
- Disclosed ownership: 3.8%.
- Date of event: 31 Mar 2026.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 3.8% | 3,142,437 | 3,142,437 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 3.8% | 3,142,437 | 3,142,437 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 3.8% | 3,142,437 | 3,142,437 | 0 | /s/ Senai Asefaw, M.D. | N/A | |
| Paradigm BioCapital International Fund Ltd. | 3.3% | 2,769,062 | 2,769,062 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |
CIK / CUSIP context first